The MaxCyte GT® Scalable Transfection System is based on Flow Electroporation™ Technology, a non-viral, inherently safe cell-engineering technology and is designed for clinical use. It has the performance, scalability and established regulatory record to overcome the existing obstacles of cell therapy and enables the development and clinical manufacturing of next-generation cell and gene therapies with enhanced biological activity.
High-Performance
Flexible
Scalable
Regulatory Pathway
Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter